Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Journal Article

Newell, A. Hanlon, Liu, W., Bubendorf, L., Buettner, R., Kerr, K., Kockx, M., Kossai, M., Lopez-Rios, F., Marchetti, A., Marondel, I., Nicholson, A., Oz, B., Pauwels, P., Penault-Llorca, F., Rossi, G., Russeler, V., Thunnissen, E., Pate, G., Portier, B., Faure, C., Le, C., Smith, D., Menzl, I. and Huang, R. (2018). ROS1 (SP384) Immunohistochemistry Inter-Reader Precision Between 12 Pathologists. J. Thorac. Oncol., 13 (10). S. S452 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Ruesseler, V., Heydt, C., Binot, E., Bubendorf, L. and Buettner, R. (2018). Testing of ROS1-positive tumours by IHC displays a FISH-positive subgroup which might not benefit form recently approved drug therapy. Virchows Arch., 473. S. S18 - 2. NEW YORK: SPRINGER. ISSN 1432-2307

Thunnissen, E., Lissenberg-Witte, B., Van den Heuvel, M., Monkhorst, K., Skov, B., Sorensen, J., Mellemgaard, A., Dingemans, A., Speel, E., De langen, J., Hashemi, S., Bahce, I., Van Der Drift, M., Buettner, R., Salomon, M. Looijen, Gosney, J., Postmus, P. E., Samii, S., Duplaquet, F., Weynand, B., Durando, X., Penault-Llorca, F., Finn, S., Oz, B., Akyurek, N., Wolf, J., Bubendorf, L., Hiemstra, A., Duin, S., Marondel, L., Timens, W., Schuuring, E., Pauwels, P. and Smit, E. (2018). Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative. J. Thorac. Oncol., 13 (10). S. S452 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Thunnissen, E., Lissenberg-Witte, B., I, van den Heuvel, M. M., Monkhorst, K., Skov, B. G., Sorensen, J. B., Mellemgaard, A., Dingemans, A. M. C., Speel, E. J. M., de Langen, A. J., Hashemi, S. M. S., Bahce, I, van der Drift, M. A., Looijen-Salamon, M. G., Gosney, J., Postmus, P. E., Samii, S. M. S., Duplaquet, F., Weynand, B., Durando, X., Penault-Llorca, F., Finn, S., Grady, A. O., Oz, B., Akyurek, N., Buettner, R., Wolf, J., Bubendorf, L., Duin, S., Marondel, I, Heukamp, L. C., Timens, W., Schuuring, E. M. D., Pauwels, P. and Smit, E. F. (2019). ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. Lung Cancer, 138. S. 13 - 19. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332

This list was generated on Fri Mar 29 13:26:03 2024 CET.